# A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia

> **NCT00176566** · PHASE2 · TERMINATED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 8 (actual)

## Conditions studied

- Oral Leukoplakia

## Interventions

- **DRUG:** Lozenge Intake

## Key facts

- **NCT ID:** NCT00176566
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-09
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Transitioned into a national study through ECOG
- **Last updated:** 2009-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176566, "A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00176566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*